Hepatocyte transplantation in animal models

Authors

  • Anne Weber,

    Corresponding author
    1. Institut National de la Santé et de la Recherche Médicale Unité 804, Université Paris-Sud, Bicêtre Hospital, Kremlin-Bicêtre, France
    • Institut National de la Santé et de la Recherche Médicale Unité 804, 80 Rue du Général Leclerc, 94276 Kremlin Bicêtre Cedex, France
    Search for more papers by this author
    • Telephone: +33149591856; FAX: +33149591959

  • Marie-Thérèse Groyer-Picard,

    1. Institut National de la Santé et de la Recherche Médicale Unité 804, Université Paris-Sud, Bicêtre Hospital, Kremlin-Bicêtre, France
    Search for more papers by this author
  • Dominique Franco,

    1. Institut National de la Santé et de la Recherche Médicale Unité 804, Université Paris-Sud, Bicêtre Hospital, Kremlin-Bicêtre, France
    2. Department of General Surgery, Antoine Béclère Hospital, Assistance Publique-Hôpitaux de Paris, Clamart, France
    Search for more papers by this author
  • Ibrahim Dagher

    1. Institut National de la Santé et de la Recherche Médicale Unité 804, Université Paris-Sud, Bicêtre Hospital, Kremlin-Bicêtre, France
    2. Department of General Surgery, Antoine Béclère Hospital, Assistance Publique-Hôpitaux de Paris, Clamart, France
    Search for more papers by this author

Abstract

More than 30 years after the first hepatocyte transplant to treat the Gunn rat, the animal model for Crigler-Najjar syndrome, there are still a number of impediments to hepatocyte transplantation. Numerous animal models are still used in work aimed at improving hepatocyte engraftment and/or long-term function. Although other cell sources, particularly hepatic and extrahepatic stem cells, are being explored, adult hepatocytes remain the cells of choice for the treatment of liver diseases by cell therapy. In recent years, diverse approaches have been developed in various animal models to enhance hepatocyte transduction and amplification in vitro and cell engraftment and functionality in vivo. They have led to significant progress in hepatocyte transplantation for the treatment of patients with metabolic diseases and for bridging patients with acute injury until their own livers regenerate. This review presents and considers the results of this work with a special emphasis on procedures that might be clinically applicable. Liver Transpl 15:7–14, 2009. © 2008 AASLD.

Ancillary